TrialInternational journal of clinical oncology2013

A phase II study of lapatinib for brain metastases in patients with HER2-overexpressing breast cancer following trastuzumab based systemic therapy and cranial radiotherapy: subset analysis of Japanese patients.

Hiroji Iwata et al.PubMed ↗Publisher ↗

No numbers read from the abstract.